StockMarketWire.com - The FTSE 100 failed to gain positive momentum as trade war concerns continued and miners remained weak.

Miners dominated the top fallers on Friday with Rio Tinto (RIO) shedding 2.3% to £35.60 and Glencore (GLEN) declined 2.1%.

BHP Billiton (BLT) and Anglo American (AAL) were also down by approximately 1.5% each.

The FTSE closed 0.2% lower at 7,183.

Brent crude oil decreased 1.5% to $67.29 per barrel. Gold gained 0.5% to $1,331 per ounce and copper cheapened 0.9% to $3.04 per pound.

OVERSEAS MARKETS

Disappointing US jobs data in March and US President Donald Trump's threat to impose $100bn worth of tariffs on Chinese goods dragged Wall Street into negative territory.

As of 5pm UK time, the Dow Jones was the biggest faller, down 1.6% at 24,118.

MID AND LARGE CAP RISERS AND FALLERS

Budget airline EasyJet (EZJ) revealed a 3.4% rise in passenger numbers in March compared to a year ago. Shares in easyJet was flat at £16.34 as investors may have expected higher figures due to the demise of other rivals last year.

SMALL CAP RISERS AND FALLERS

Car dealer Motorpoint (MOTR) accelerated 10.6% to 240p after announcing profit is anticipated to reach the top end of expectations despite cautious optimism on the UK used car market.

Equipment hire specialist VP (VP.) announced it will reveal full year results in line with expectations, driven by strong progress over the winter period, pushing its shares 7.5% higher to 881.5p.

Electricals retailer AO World (AO.) sparked 13.1% to 129.8p after reporting full year sales are expected to hit the top end of analysts' expectations.

Fuel technology firm Quadrise Fuels (QFI) warned a project in Saudi Arabia that was expected to trial its fuel technology is unlikely to proceed as planned, triggering a 12.1% drop in the shares to 3.3p.

Shield Therapeutics (STX) rallied 23.4% to 19.1p after US regulatory authorities said it did not have to conduct additional clinical trials before submitting a new drug application for iron deficiency drug Feraccru.


Story provided by StockMarketWire.com